当前位置:首页 - 行情中心 - 微芯生物(688321) - 财务分析

微芯生物

(688321)

  

流通市值:127.73亿  总市值:138.73亿
流通股本:4.08亿   总股本:4.43亿

微芯生物(688321)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.28亿元,每股收益0.07元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益258458.52万元,未分配利润7403.64万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产458193.28万元,负债199734.77万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入257,038,676.31910,061,840.72674,157,709.09406,598,517.7
营业总成本224,552,523.96846,023,589.62597,523,641.23376,480,827.83
其他经营收益
营业利润28,896,419.9450,111,980.9770,399,030.328,120,919.48
利润总额28,652,328.9150,052,450.5370,314,760.3528,065,637.36
净利润28,271,869.0450,959,162.5670,767,514.8529,592,228.83
每股收益
其他综合收益-673,116.67-972,852.61-516,553.25-209,350.4
综合收益总额27,598,752.3749,986,309.9570,250,961.629,382,878.43
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,064,481,235.61,180,388,674.711,338,524,487.151,246,399,390.82
非流动资产:
非流动资产合计2,517,451,590.72,470,107,721.122,294,668,340.762,188,403,802.3
资产总计4,581,932,826.33,650,496,395.833,633,192,827.913,434,803,193.12
流动负债:
流动负债合计805,157,918.65843,902,453.31716,038,451.58650,505,729.15
非流动负债:
非流动负债合计1,192,189,750.851,180,769,878.51,261,270,465.271,169,543,706.34
负债合计1,997,347,669.52,024,672,331.811,977,308,916.851,820,049,435.49
所有者权益(或股东权益):
归属于母公司股东权益合计2,584,585,156.81,625,824,064.021,655,883,911.061,614,753,757.63
股东权益合计2,584,585,156.81,625,824,064.021,655,883,911.061,614,753,757.63
负债和股东权益合计4,581,932,826.33,650,496,395.833,633,192,827.913,434,803,193.12
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计270,052,993.79878,200,278.36637,831,624.93433,184,403.84
经营活动现金流出小计245,709,035.68781,234,920.07577,909,550.15371,125,906.32
经营活动产生的现金流量净额24,343,958.1196,965,358.2959,922,074.7862,058,497.52
投资活动产生的现金流量:
投资活动现金流入小计310,160,743.121,667,499,604.241,110,864,563.78696,041,367.29
投资活动现金流出小计1,004,357,608.991,885,115,121.581,259,808,047.82745,964,987.8
投资活动产生的现金流量净额-694,196,865.87-217,615,517.34-148,943,484.04-49,923,620.51
筹资活动产生的现金流量:
筹资活动现金流入小计1,048,863,997.44491,902,465401,885,265197,000,000
筹资活动现金流出小计135,646,418.42364,302,314.7237,912,188.88102,310,830.17
筹资活动产生的现金流量净额913,217,579.02127,600,150.3163,973,076.1294,689,169.83
汇率变动对现金及现金等价物的影响-788,180.1-807,474.93-1,729,409.36-77,413.06
现金及现金等价物净增加额242,576,491.166,142,516.3273,222,257.5106,746,633.78
期末现金及现金等价物余额471,259,416.34228,682,925.18295,762,666.36329,287,042.64
补充资料:
现金及现金等价物的净增加额-6,142,516.32-106,746,633.78
最新报告期:2026-04-14
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中信建投沈毅,袁清慧,魏佳奥0.320.630.862026-04-14
国泰海通周航,余克清,余文心,廖博闻0.120.380.672026-03-10
方正证券许睿,周超泽,李霁阳0.471.04--2026-02-10
TOP↑